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require special scrutiny: daily chest x-ray
films are recommended only for patients
with respiratory failure supported by
mechanical ventilation or for acute cardio-
pulmonary problems. This does not com-






In Germany, government regulations re-
quire that each radiograph be ordered by
a physician with a documented clinical indi-
cation (http://www.bmu.de [homepage of
the German Federal Ministry for the Envi-
ronment, Nature Conservation and Nuclear
Safety, last accessed August 2007]). There-
fore, radiologic assessment of a patient
solely on a routine daily basis is actually
illegal. A change in the clinical status of a
patient (eg, laboratory findings, new chest
tube) and a lack of alternative diagnostic
tools (eg, ultrasound) have to be present be-
fore a chest radiograph is performed. This
reflects the fact that any unnecessary radia-
tion exposure should be avoided.
We hope that this study further helps to
abandon the seemingly still common prac-
tice of daily routine chest radiographs.
Utz Kappert, MDa
Sebastian N. Stehr, MDb
Klaus Matschke, MDa
Department of Cardiac Surgerya
Department of Anesthesiology and
Intensive Care Medicineb
University of Technology Dresden
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Reply to the Editor:
We appreciate the attention paid by Kap-
pert, Stehr, and Matschke to our article
concerning the elimination of daily routine
chest radiographs in post–cardiothoracic
surgery patients.1 They raised several is-
sues, which we would like to address point
by point.
First, it may seem surprising that the
ethics committee deemed it unnecessary to
obtain informed consent when abolishing
a daily routine strategy. However, it was in
fact a medical decision to change the policy
of obtaining daily routine chest radiographs
in view of all the data indicating its limited
value.2 This study was used to evaluate the
effects of that medical decision. In addition,
in a separate prospective study, daily routine
chest radiographs were blinded to attending
physicians but evaluated by trained radiolo-
gists, that is, unsuspected predefined major
abnormalities were disclosed and communi-
cated with attending intensive care unit phy-
sicians.3 In that study, we demonstrated that
the number of unsuspected predefined major
abnormalities on daily routine chest radio-
graphs was low (4.4%) and the number of
radiographs resulting in a change in therapy
was even lower (1.9%).
Second, we agree with Kappert, Stehr,
and Matschke that the current American
College of Radiology guidelines only rec-
ommend chest radiographs for patients
with respiratory failure supported by me-
chanical ventilation or with acute cardiopul-
monary problems. Indeed, this is not the
case in all cardiothoracic patients.
Third, it is interesting to read that a daily
routine strategy for obtaining chest radio-
graphs is in fact prohibited by law in Ger-
many. At least in the Netherlands, a daily
routine strategy for obtaining chest radio-
graphs in every patient in the intensive
care unit is still frequently practiced,4 al-
though in our experience this extends to
many other countries in the world. We fully
agree with Kappert, Stehr, and Matschke in
hoping that this approach will change in
view of all the available evidence.
P. E. Spronk, MD, PhD
M. J. Schultz, MD, PhD
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Do age or incorrect data
analysis have any impact on
clinical outcome?
To the Editor:
Within the frame of a general concern about
the quality of scientific articles published in
peer-review international journals, I would
like to make some considerations regarding
the manuscript by Ruol and colleagues1 re-
cently published in the Journal of Thoracic
and Cardiovascular Surgery, titled ‘‘Re-
sults of Esophagectomy for Esophageal
Cancer in Elderly Patients: Age Has Little
Influence on Outcome and Survival.’’
The authors conclude that age should not
be considered a contraindication for elderly
patients (.70 years) because in their retro-
spective study no significant survival dif-
ference was found between elderly and
younger patients.
In the light of the large series described,
the authors had the opportunity of providing
the scientific community with a clinically
relevant piece of information: unfortunately,
owing to some evident limits in their data
analysis, Ruol and colleagues have missed
this opportunity by significantly undermin-
ing the reliability of their work.
My perplexities on this article mainly
arise from the following considerations,
which are mainly statistical in nature:
1. The authors state they used the
Kaplan–Meier method to compute
survival estimates, which is virtually
the only method used worldwide to
this aim. However, the curves
Reply to the Editor:
We appreciate Dr Yung’s concerns about
the quality of scientific articles published
in peer-reviewed journals such as the
Journal of Thoracic and Cardiovascular
Surgery, which are read by thousands of
specialists in both thoracic and general
surgery. It has been a privilege for us
to have our data published in the Journal
Letters to the Editorillustrated in Figures 1 and 2 are not
generated with the Kaplan–Meier
method, as anybody familiar with
this statistical approach can readily
confirm (eg, no staircase appearance,
both curves end at 5 years in both
figures, symbols are used to differen-
tiate study groups instead of cen-
sored/uncensored data that are not
reported anywhere in the article).
The authors should explain how
they built the curves: in other words,
if they did not use a statistical soft-
ware—as it appears—they must ex-
plain according to what rules they
drew the curves that do not appear
to take into account the difference
between censored and uncensored
data (ie, the foundation of survival
analysis). The reason for the discrep-
ancy between the method cited in the
‘‘Methods’’ section and the figures
shown in the ‘‘Results’’ section
should be explained and the error
corrected.
2. In the text (‘‘Results’’ section), the
median survival appears to be 17.9
and 23.1 months for the elderly and
the younger group of patients, re-
spectively. However, likely because
of the aforementioned issue, the me-
dian survivals extrapolated from the
curves depicted in Figure 1 are strik-
ingly different (roughly 23 and 30
months, respectively). This is further
proof that something is wrong with
the survival analysis reported by
Ruol and colleagues.
3. In the ‘‘Discussion’’ section the au-
thors keep repeating that the study
was specifically designed to investi-
gate the impact of age on the clinical
outcome. Nevertheless, they did not
provide any study design in the
‘‘Methods’’ section. In particular,
they did not specify the power of
the study, which is of paramount im-
portance to correctly interpret their
findings. Since their conclusion is
that no survival difference was de-
tected between the two study groups,
what is the error beta of this analysis?
In other words, what is the likelihood
that the null hypothesis (no differ-
ence between survivals) was incor-
rectly accepted? Or, the other way
around, what is the median survivaldifference detectable with the sam-
ple size considered in the study?
4. In the Cox model, the authors chose
to include seven covariates: besides
age, which was the variable specifi-
cally targeted by the study, the
choice of the other variables appears
quite ‘‘random.’’ In fact, if one can
agree on the choice of the variables
resulted significant at the univariate
analysis reported in Table 7 (ie, tu-
mor stage and grading); however,
it is more difficult to understand
why the authors included other non-
significant variables (ie, sex, tumor
location, neoadjuvant therapy, his-
tologic type) while they completely
omitted significant variables, such
as those reported in Table 2 (ie, his-
tory of respiratory disease, history
of vascular disease, and American
Society of Anesthesiologists classi-
fication). Since the number and the
type (informative vs confounding)
of variables included in the model
can profoundly affect the final re-
sult, the authors should explain the
reasons for their choice and provide
data on models built with all the var-
iables yielding significant results at
univariate analysis.
5. In Table 8 (results of the Cox
model), the authors reported the c2
values for each covariate: clearly
this information is meaningless to
most readers, who are certainly
much more interested to know the
hazard ratio associated with each
covariate (ie, the risk of death of
the covariate categories as compared
with the baseline category). Again,
the choice of the authors appears
unfounded and leaves some doubts
on the statistical competence of the
person(s) who took care of the data
analysis.
6. Although there is a significant differ-
ence in preoperative risk (as assessed
by the American Society of Anesthe-
siologists score system) between the
two study groups (Table 2), the post-
operative death rates are almost
identical (Table 6). If confirmed,
this is a potentially useful piece of
information that has been com-
pletely overlooked in the ‘‘Discus-
sion’’ section. If the authors are
confident in their data, they shouldThe Journal of Thoracic and Cardiovascuprobably let the American Society
of Anesthesiologists know that the
most commonly used preoperative
risk assessment score likely does
not work with patients affected
with esophageal cancer.
Overall, I am aware that the above list re-
sembles a second revision rather than a com-
mentary on an article already published. In
this regard, I believe that the review process
in this specific case has failed to detect some
significant limits of the manuscript and thus
the responsibility of such ‘‘limping’’ publi-
cation is not to be attributable only to the au-
thors. On the other hand, I hope everybody
will agree that clinical research cannot be
thought of as a list of therapeutic interven-
tions with approximate data analysis, inas-
much as no scientifically and/or clinically
meaningful information can derive from
such an approach.
If we intend to make advances in medi-
cine (as well as in any other field) by publish-
ing the experiences of research groups in
scientific journals so that other researchers
can take advantage of the published data,
we must guarantee that the information is
at least formally correct.
In this specific case, I would recommend
that the authors have the data analysis
revised by a biostatistician and then publish
a letter with the explanations and corrections
necessary to recover the reliability of their
work.
William Yung, MD
Department of Medical Oncology
University of Alabama at Birmingham
Birmingham, Ala
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